Rimonabant for overweight and "metabolic syndrome": the attempt to supersize disease and risk by pharmaceutical marketing
- PMID: 18317866
- DOI: 10.1007/s11739-008-0139-x
Rimonabant for overweight and "metabolic syndrome": the attempt to supersize disease and risk by pharmaceutical marketing
Comment on
-
Rimonabant for overweight or obesity.Cochrane Database Syst Rev. 2006 Oct 18;2006(4):CD006162. doi: 10.1002/14651858.CD006162.pub2. Cochrane Database Syst Rev. 2006. PMID: 17054276 Free PMC article.

